Highland Capital Management LLC Sells 130 Shares of CME Group Inc. (NASDAQ:CME)

Highland Capital Management LLC reduced its position in shares of CME Group Inc. (NASDAQ:CMEGet Rating) by 0.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,622 shares of the financial services provider’s stock after selling 130 shares during the period. Highland Capital Management LLC’s holdings in CME Group were worth $4,017,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. MUFG Americas Holdings Corp raised its position in CME Group by 3.8% in the first quarter. MUFG Americas Holdings Corp now owns 16,886 shares of the financial services provider’s stock worth $4,017,000 after acquiring an additional 611 shares during the period. Assenagon Asset Management S.A. increased its stake in shares of CME Group by 2,556.7% in the first quarter. Assenagon Asset Management S.A. now owns 133,100 shares of the financial services provider’s stock worth $31,659,000 after purchasing an additional 128,090 shares in the last quarter. Capital International Sarl increased its stake in shares of CME Group by 14.9% in the first quarter. Capital International Sarl now owns 126,176 shares of the financial services provider’s stock worth $30,012,000 after purchasing an additional 16,316 shares in the last quarter. GHP Investment Advisors Inc. increased its stake in shares of CME Group by 4.9% in the first quarter. GHP Investment Advisors Inc. now owns 10,035 shares of the financial services provider’s stock worth $2,387,000 after purchasing an additional 472 shares in the last quarter. Finally, IndexIQ Advisors LLC purchased a new position in shares of CME Group in the first quarter worth about $27,000. 85.56% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on CME. Atlantic Securities upgraded shares of CME Group from a “neutral” rating to an “overweight” rating and set a $235.00 target price for the company in a research note on Friday, June 10th. Morgan Stanley reduced their target price on shares of CME Group from $242.00 to $226.00 and set an “equal weight” rating for the company in a research note on Thursday, July 28th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of CME Group from $208.00 to $212.00 and gave the stock a “hold” rating in a research note on Friday, August 12th. Jefferies Financial Group assumed coverage on shares of CME Group in a research note on Tuesday, May 31st. They issued a “buy” rating and a $267.00 target price for the company. Finally, Rosenblatt Securities assumed coverage on shares of CME Group in a research note on Tuesday, August 16th. They set a “sell” rating and a $171.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus price target of $230.80.

CME Group Stock Up 0.7 %

Shares of NASDAQ:CME opened at $183.33 on Friday. CME Group Inc. has a 52-week low of $181.29 and a 52-week high of $256.94. The firm has a fifty day moving average of $198.51 and a 200 day moving average of $210.51. The firm has a market capitalization of $65.90 billion, a PE ratio of 22.75, a price-to-earnings-growth ratio of 2.93 and a beta of 0.40. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CMEGet Rating) last announced its earnings results on Wednesday, July 27th. The financial services provider reported $1.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.92 by $0.05. CME Group had a net margin of 60.43% and a return on equity of 9.65%. The company had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.25 billion. During the same period in the previous year, the business earned $1.64 earnings per share. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. As a group, research analysts anticipate that CME Group Inc. will post 7.96 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 27th. Shareholders of record on Friday, September 9th will be paid a $1.00 dividend. This represents a $4.00 annualized dividend and a yield of 2.18%. The ex-dividend date is Thursday, September 8th. CME Group’s dividend payout ratio is presently 49.63%.

Insiders Place Their Bets

In other CME Group news, insider Timothy Francis Mccourt sold 360 shares of the business’s stock in a transaction on Monday, September 19th. The shares were sold at an average price of $190.77, for a total value of $68,677.20. Following the completion of the sale, the insider now directly owns 5,431 shares of the company’s stock, valued at $1,036,071.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other CME Group news, insider Timothy Francis Mccourt sold 360 shares of the business’s stock in a transaction on Monday, September 19th. The shares were sold at an average price of $190.77, for a total value of $68,677.20. Following the completion of the sale, the insider now directly owns 5,431 shares of the company’s stock, valued at $1,036,071.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Daniel R. Glickman sold 500 shares of the business’s stock in a transaction on Wednesday, August 31st. The stock was sold at an average price of $196.39, for a total transaction of $98,195.00. Following the completion of the sale, the director now directly owns 14,597 shares of the company’s stock, valued at $2,866,704.83. The disclosure for this sale can be found here. Insiders sold 10,511 shares of company stock valued at $2,123,186 over the last three months. Insiders own 0.30% of the company’s stock.

About CME Group

(Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.